Aug 09, 2023 / 06:00PM GMT
Caitlin Cronin - Canaccord Genuity Group Inc. - Analyst
Good morning. My name is Caitlin Cronin -- or good afternoon. My name is Caitlin Cronin, and I'm one of the medical device analysts here at Canaccord Genuity. Thank you for joining us at this year's Canaccord Genuity Growth Conference.
I'm joined today by Axogen, a regenerative-medicine company and market leader in the field of peripheral nerve repair. We're very pleased to be joined today by Karen Zaderej, CEO.
And before we begin, I want to remind everyone of any relevant disclosures which can be found on our conference and firm website. We're going to begin with a brief presentation followed by some Q&A. And with that, I'll turn it over to Karen.
Karen Zaderej - Axogen, Inc. - President, CEO, and Chairman
Thank you, Caitlin, and thank you, everybody, for joining us today. So Axogen is a company focused in the area of peripheral nerve repair. And we're the only exclusive company focused in this area, we think it's a tremendous area of untapped potential. We've been in the market
AxoGen Inc at Canaccord Genuity Growth Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot